Ferrologix: Innovating cell therapy with patented digital magnetic sorting technology since 2015.

Kytopen: Streamlining cell therapy with automated, cost-effective non-viral molecule delivery solutions.

CERo Therapeutics, Inc.: A pioneering cell therapy firm integrating innate and adaptive programs to combat disease.

AlphaStem pioneers in cell-based therapy for cardiovascular disease.

Orca Bio: A clinical-stage cell therapy firm innovating curative treatments for over 100 diseases.

Appia Bio: Pioneering scalable cell therapy technologies for broad healthcare applications since 2020.

US-based Sentien Biotechnologies innovates in cell therapy and drug delivery systems to treat acute inflammatory diseases.

Tychon Bioscience: Innovating adaptive immunotherapy for targeted anti-tumor cell therapies.

San Francisco-based cell therapy provider, partnering with global innovators to advance and commercialize novel therapeutics.

Tr1x: Pioneering cellular therapies for autoimmune disorders, recalibrating the immune system for long-term tolerance.

Regenevida: Pioneering regenerative medicine with transplantable cells to improve human health.

Tissue Genesis: Innovating advanced tissue engineering and cell therapy solutions since 2001, with a focus on vascular disease.

US-based PlateletBio pioneers in allogeneic cell therapy, innovating superior solutions for unmet medical challenges.

Stemson Therapeutics: Pioneering pre-clinical cell therapy for safe, natural hair restoration.

Elixirgen Therapeutics: A Maryland-based biotech firm innovating in stem cell biology and RNA technology.

An innovative CDMO specializing in cell and gene therapy development and manufacturing.

Coda Biotherapeutics: A tech firm innovating in cell therapy and chemogenetic neuronal modulation.

WindMIL Therapeutics: Innovating cell-based immuno-oncology therapies using proprietary MILs™ technology.

Evia Bio, a Minneapolis-based software company, innovates non-DMSO cryopreservation tech for cell therapy.

Penn Medicine Fund investing in cell therapy, gene therapy, and connected health spinouts.

Vascugen: Advancing iPSC therapy with engineered vascular cells for ischemic disease treatment.

Coeptis Pharmaceuticals: Developing generic drugs and cancer cell therapy platforms in the US.

Pathfinder Cell Therapy: Innovating cell-based treatments for organ-specific diseases and damage.

Likarda: A biotech firm revolutionizing cell therapy delivery and optimization with Core-Shell Spherification® technology.

ElevateBio, a cell and gene therapy firm, develops and commercializes transformative medicines, swiftly turning R&D into viable therapies.